Approach to the Patient: Safety of Growth Hormone Replacement in Children and Adolescents
- 12 October 2021
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 107 (3) , 847-861
Abstract
The use of recombinant human growth hormone (rhGH) in children and adolescents has expanded since its initial approval to treat patients with severe GH deficiency (GHD) in 1985. rhGH is now approved to treat several conditions associated with poor growth and short stature. Recent studies have raised concerns that treatment during childhood may affect morbidity and mortality in adulthood, with specific controversies over cancer risk and cerebrovascular events. We will review 3 common referrals to a pediatric endocrinology clinic, followed by a summary of short- and long-term effects of rhGH beyond height outcomes. Methods to mitigate risk will be reviewed. Finally, this information will be applied to each clinical case, highlighting differences in counseling and clinical outcomes. rhGH therapy has been used for more than 3 decades. Data are largely reassuring, yet we still have much to learn about pharmaceutical approaches to growth in children and the lifelong effect of treatment.Keywords
This publication has 88 references indexed in Scilit:
- Growth hormone improves growth in pediatric renal transplant recipients—a systemic review and meta-analysis of randomized controlled trialsPediatric Nephrology, 2012
- Growth Hormone: The Expansion of Available Products and IndicationsPediatric Clinics of North America, 2011
- Short Stature: Psychosocial InterventionsHormone Research in Paediatrics, 2011
- Risk of colorectal neoplasm in patients with acromegaly: A meta-analysisWorld Journal of Gastroenterology, 2008
- Growth hormone and thyroid function-interaction and inhibition.Nature Clinical Practice Endocrinology & Metabolism, 2007
- Death in two female Prader‐Willi syndrome patients during the early phase of growth hormone treatmentActa Paediatrica, 2005
- Sudden death in growth hormone–treated children with Prader-Willi syndromeThe Journal of Pediatrics, 2004
- Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studiesActa Paediatrica, 1996
- Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormoneThe Journal of Pediatrics, 1995
- Metabolic Effects of Human and Monkey Growth Hormone in ManScience, 1957